Skip to content

Insider · CIK 0001775404

Stacy J. Kanter

director

Files at OPY (OPPENHEIMER HOLDINGS INC), APLT (Applied Therapeutics, Inc.). First filing Dec 18, 2025, latest Dec 18, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $4,816 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
25Weak
APLTsell
Applied Therapeutics, Inc.
$4,816
43,000 shares
-40%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 26, 2026OPY
OPPENHEIMER HOLDINGS INC
JOther
Class A non-voting common stock
+1,400--5,900Feb 27, 2026
Feb 3, 2026APLT
Applied Therapeutics, Inc.
DDisposition to issuer
Common Stock
-22,500--42,500Feb 4, 2026
Feb 3, 2026APLT
Applied Therapeutics, Inc.
UTender of shares
Common Stock
-42,500--0Feb 4, 2026
Feb 3, 2026APLT
Applied Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-20,460--0Feb 4, 2026
Feb 3, 2026APLT
Applied Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-10,230--0Feb 4, 2026
Feb 3, 2026APLT
Applied Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-16,500--0Feb 4, 2026
Feb 3, 2026APLT
Applied Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-16,500--0Feb 4, 2026
Feb 3, 2026APLT
Applied Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-200,000--0Feb 4, 2026
Dec 16, 2025APLT
Applied Therapeutics, Inc.
SOpen-market sale
Common Stock
-43,000$0.11$4,81665,000Dec 18, 2025
Jun 9, 2025APLT
Applied Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+200,000$0.00$0200,000Jun 11, 2025
Jan 30, 2025OPY
OPPENHEIMER HOLDINGS INC
JOther
Class A non-voting common stock
+1,500--4,500Jan 31, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stacy J. Kanter: insider trades and track record | InsiderTell